Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 125

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1A
Chunk 125
---
** 
     -  
     -  
     6  
     (6) 
     -  
     - 
  
    Adjusted Balances, beginning of period* 
     646,264  
    $6  
    $-  
    $(10,770) 
    $675  
    $(10,089)
  
    Reclassification of additional paid-in-capital *** 
     -  
     -  
     (6) 
     6  
     -  
     - 
  
    Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date (Note 2) 
     3,735  
     -  
     3,685  
     -  
     -  
     3,685 
  
    Issuance of common stock upon conversion of MURF Class A & Class B common stock in connection with merger (Note 2) 
     41,183  
     1  
     (15,219) 
     -  
     -  
     (15,218)
  
    Issuance of Conduit Pharmaceuticals Inc. common stock in connection with PIPE Financing (Note 2) 
     20,000  
     -  
     19,779  
     -  
     -  
     19,779 
  
    Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC 
     3,955  
     -  
     151  
     -  
     -  
     151 
  
    Issuance of Conduit Pharmaceuticals Inc. common stock to Vela Technologies PLC 
     10,158  
     -  
     544  
     -  
     -  
     544 
  
    Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the Merger (Note 2) 
     13,000  
     -  
     -  
     -  
     -  
     - 
  
    Reduction of excise tax liability associated with the Merger (Note2) 
     -  
     -  
     1,141